Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. (Q48372615)
Jump to navigation
Jump to search
scientific article published on 13 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. |
scientific article published on 13 November 2006 |
Statements
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy (English)
Yuan L
Siegel M
Khosla C
Jackson EN
Piwnica-Worms D
13 November 2006
1 reference
1 reference